Smart-Money SignalNeutral · 43/100— Insiders are net sellers over 90 days (-$27K, 4 sales vs 4 buys)
Revenue$11.7M
Net Income$36.3M
EPS$0.00
Market Cap$72.7M
Price Performance
Historical data including institutional events
Company Profile
N
Nicholas Curtis
CEO & Executive Director
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System.
The company offers LENSAR Laser System which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes by providing imaging, procedure planning, design, and precision.
It also provides ALLY Robotic Cataract Laser System, a compact cataract treatment system that is designed to allow surgeons to perform sterile laser-assisted cataract surgery in a single operating room.
LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.
